ID   ZDHC3_RAT               Reviewed;         299 AA.
AC   Q2TGK3;
DT   17-JUN-2020, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2006, sequence version 1.
DT   02-OCT-2024, entry version 137.
DE   RecName: Full=Palmitoyltransferase ZDHHC3 {ECO:0000305};
DE            EC=2.3.1.225 {ECO:0000250|UniProtKB:Q8R173};
DE   AltName: Full=Acyltransferase ZDHHC3 {ECO:0000250|UniProtKB:Q8R173};
DE            EC=2.3.1.- {ECO:0000250|UniProtKB:Q8R173};
DE   AltName: Full=Zinc finger DHHC domain-containing protein 3 {ECO:0000312|RGD:1309041};
GN   Name=Zdhhc3 {ECO:0000312|RGD:1309041};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Huang C.-H., Chen Y., Peng J., Ye T.;
RT   "A superfamily of membrane-associated DHHC type zinc finger proteins.";
RL   Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19596852; DOI=10.1083/jcb.200903101;
RA   Noritake J., Fukata Y., Iwanaga T., Hosomi N., Tsutsumi R., Matsuda N.,
RA   Tani H., Iwanari H., Mochizuki Y., Kodama T., Matsuura Y., Bredt D.S.,
RA   Hamakubo T., Fukata M.;
RT   "Mobile DHHC palmitoylating enzyme mediates activity-sensitive synaptic
RT   targeting of PSD-95.";
RL   J. Cell Biol. 186:147-160(2009).
CC   -!- FUNCTION: Golgi-localized palmitoyltransferase that catalyzes the
CC       addition of palmitate onto various protein substrates. Has no stringent
CC       fatty acid selectivity and in addition to palmitate can also transfer
CC       onto target proteins myristate from tetradecanoyl-CoA and stearate from
CC       octadecanoyl-CoA (By similarity). Plays an important role in G protein-
CC       coupled receptor signaling pathways involving GNAQ and potentially
CC       other heterotrimeric G proteins by regulating their dynamic association
CC       with the plasma membrane (By similarity). Palmitoylates ITGA6 and
CC       ITGB4, thereby regulating the alpha-6/beta-4 integrin localization,
CC       expression and function in cell adhesion to laminin (By similarity).
CC       Plays a role in the TRAIL-activated apoptotic signaling pathway most
CC       probably through the palmitoylation and localization to the plasma
CC       membrane of TNFRSF10A (By similarity). In the brain, by palmitoylating
CC       the gamma subunit GABRG2 of GABA(A) receptors and regulating their
CC       postsynaptic accumulation, plays a role in synaptic GABAergic
CC       inhibitory function and GABAergic innervation. Palmitoylates the
CC       neuronal protein GAP43 which is also involved in the formation of
CC       GABAergic synapses. Palmitoylates NCDN thereby regulating its
CC       association with endosome membranes. Probably palmitoylates PRCD and is
CC       involved in its proper localization within the photoreceptor. Could
CC       mediate the palmitoylation of NCAM1 and regulate neurite outgrowth.
CC       Could palmitoylate DNAJC5 and regulate its localization to Golgi
CC       membranes (By similarity). Also constitutively palmitoylates DLG4
CC       (PubMed:19596852). May also palmitoylate SNAP25. Could palmitoylate the
CC       glutamate receptors GRIA1 and GRIA2 but this has not been confirmed in
CC       vivo (By similarity). Could also palmitoylate the D(2) dopamine
CC       receptor DRD2 (By similarity). May also palmitoylate LAMTOR1, promoting
CC       its localization to lysosomal membranes (By similarity). Palmitoylates
CC       the Toll-like receptor 9/TLR9 in the Golgi and thereby regulates TLR9
CC       trafficking to endosomes (By similarity). May palmitoylate CALHM1 and
CC       CALHM3 subunits of gustatory voltage-gated ion channels and modulate
CC       channel gating and kinetics. {ECO:0000250|UniProtKB:Q8R173,
CC       ECO:0000250|UniProtKB:Q9NYG2, ECO:0000269|PubMed:19596852}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=hexadecanoyl-CoA + L-cysteinyl-[protein] = CoA + S-
CC         hexadecanoyl-L-cysteinyl-[protein]; Xref=Rhea:RHEA:36683, Rhea:RHEA-
CC         COMP:10131, Rhea:RHEA-COMP:11032, ChEBI:CHEBI:29950,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57379, ChEBI:CHEBI:74151;
CC         EC=2.3.1.225; Evidence={ECO:0000250|UniProtKB:Q8R173};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36684;
CC         Evidence={ECO:0000250|UniProtKB:Q8R173};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-cysteinyl-[protein] + tetradecanoyl-CoA = CoA + S-
CC         tetradecanoyl-L-cysteinyl-[protein]; Xref=Rhea:RHEA:59736, Rhea:RHEA-
CC         COMP:10131, Rhea:RHEA-COMP:15433, ChEBI:CHEBI:29950,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57385, ChEBI:CHEBI:143199;
CC         Evidence={ECO:0000250|UniProtKB:Q8R173};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:59737;
CC         Evidence={ECO:0000250|UniProtKB:Q8R173};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-cysteinyl-[protein] + octadecanoyl-CoA = CoA + S-
CC         octadecanoyl-L-cysteinyl-[protein]; Xref=Rhea:RHEA:59740, Rhea:RHEA-
CC         COMP:10131, Rhea:RHEA-COMP:15434, ChEBI:CHEBI:29950,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57394, ChEBI:CHEBI:143200;
CC         Evidence={ECO:0000250|UniProtKB:Q8R173};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:59741;
CC         Evidence={ECO:0000250|UniProtKB:Q8R173};
CC   -!- SUBUNIT: Monomer. Homooligomers. The monomeric form has a higher
CC       catalytic activity. Forms heterooligomers with ZDHHC7 (By similarity).
CC       Interacts with TNFRSF10A (By similarity).
CC       {ECO:0000250|UniProtKB:Q8R173, ECO:0000250|UniProtKB:Q9NYG2}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane
CC       {ECO:0000269|PubMed:19596852}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=Localizes to the Golgi cis cisterna.
CC       {ECO:0000250|UniProtKB:Q8R173}.
CC   -!- DOMAIN: The DHHC domain is required for palmitoyltransferase activity.
CC       {ECO:0000250|UniProtKB:Q8IUH5}.
CC   -!- PTM: Phosphorylation by FGFR1 and SRC probably regulates the
CC       palmitoyltransferase activity. {ECO:0000250|UniProtKB:Q8R173}.
CC   -!- PTM: Autopalmitoylated. {ECO:0000250|UniProtKB:Q8R173}.
CC   -!- SIMILARITY: Belongs to the DHHC palmitoyltransferase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY886522; AAX73384.1; -; mRNA.
DR   EMBL; AC133294; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH473954; EDL76770.1; -; Genomic_DNA.
DR   EMBL; BC128697; AAI28698.1; -; mRNA.
DR   RefSeq; NP_001034103.1; NM_001039014.1.
DR   RefSeq; XP_006244250.1; XM_006244188.3.
DR   AlphaFoldDB; Q2TGK3; -.
DR   SMR; Q2TGK3; -.
DR   STRING; 10116.ENSRNOP00000005817; -.
DR   iPTMnet; Q2TGK3; -.
DR   PhosphoSitePlus; Q2TGK3; -.
DR   SwissPalm; Q2TGK3; -.
DR   PaxDb; 10116-ENSRNOP00000005817; -.
DR   Ensembl; ENSRNOT00000005817.7; ENSRNOP00000005817.5; ENSRNOG00000004344.8.
DR   Ensembl; ENSRNOT00055003605; ENSRNOP00055002706; ENSRNOG00055002266.
DR   Ensembl; ENSRNOT00060035384; ENSRNOP00060029082; ENSRNOG00060020429.
DR   Ensembl; ENSRNOT00065000865; ENSRNOP00065000699; ENSRNOG00065000610.
DR   GeneID; 301081; -.
DR   KEGG; rno:301081; -.
DR   UCSC; RGD:1309041; rat.
DR   AGR; RGD:1309041; -.
DR   CTD; 51304; -.
DR   RGD; 1309041; Zdhhc3.
DR   eggNOG; KOG1311; Eukaryota.
DR   GeneTree; ENSGT00940000155721; -.
DR   HOGENOM; CLU_048061_1_1_1; -.
DR   InParanoid; Q2TGK3; -.
DR   OMA; CFESNWT; -.
DR   OrthoDB; 6683at2759; -.
DR   PhylomeDB; Q2TGK3; -.
DR   TreeFam; TF319798; -.
DR   PRO; PR:Q2TGK3; -.
DR   Proteomes; UP000002494; Chromosome 8.
DR   Proteomes; UP000234681; Chromosome 8.
DR   Bgee; ENSRNOG00000004344; Expressed in lung and 18 other cell types or tissues.
DR   ExpressionAtlas; Q2TGK3; baseline and differential.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016409; F:palmitoyltransferase activity; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0019705; F:protein-cysteine S-myristoyltransferase activity; IEA:RHEA.
DR   GO; GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; ISO:RGD.
DR   GO; GO:0140439; F:protein-cysteine S-stearoyltransferase activity; IEA:RHEA.
DR   GO; GO:0044873; P:lipoprotein localization to membrane; ISO:RGD.
DR   GO; GO:1902685; P:positive regulation of receptor localization to synapse; ISO:RGD.
DR   GO; GO:0032230; P:positive regulation of synaptic transmission, GABAergic; ISO:RGD.
DR   GO; GO:0034165; P:positive regulation of toll-like receptor 9 signaling pathway; ISO:RGD.
DR   GO; GO:1903546; P:protein localization to photoreceptor outer segment; ISO:RGD.
DR   GO; GO:0072659; P:protein localization to plasma membrane; ISO:RGD.
DR   GO; GO:0006605; P:protein targeting; ISO:RGD.
DR   GO; GO:0006612; P:protein targeting to membrane; IBA:GO_Central.
DR   GO; GO:0008277; P:regulation of G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0036462; P:TRAIL-activated apoptotic signaling pathway; ISO:RGD.
DR   InterPro; IPR001594; Palmitoyltrfase_DHHC.
DR   PANTHER; PTHR12246; PALMITOYLTRANSFERASE ZDHHC16; 1.
DR   PANTHER; PTHR12246:SF13; PALMITOYLTRANSFERASE ZDHHC16; 1.
DR   Pfam; PF01529; DHHC; 1.
DR   PROSITE; PS50216; DHHC; 1.
PE   2: Evidence at transcript level;
KW   Acyltransferase; Golgi apparatus; Lipoprotein; Membrane; Palmitate;
KW   Phosphoprotein; Reference proteome; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..299
FT                   /note="Palmitoyltransferase ZDHHC3"
FT                   /id="PRO_0000449923"
FT   TOPO_DOM        1..47
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        48..68
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        69..72
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        73..93
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        94..171
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        172..192
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        193..214
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        215..235
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        236..299
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          128..254
FT                   /note="DHHC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00067"
FT   ACT_SITE        157
FT                   /note="S-palmitoyl cysteine intermediate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00067"
FT   MOD_RES         18
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8R173"
FT   LIPID           146
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8R173"
SQ   SEQUENCE   299 AA;  34113 MW;  FE8BC32B21355031 CRC64;
     MMLIPTHHFR DIERKPEYLQ PEKCAPPPFP GPVGTMWFIR DGCGIACAIV TWFLVLYAEF
     VVLFVMLIPS RDYAYSIING IVFNLLAFLA LASHCRAMLT DPGAVPKGNA TKEFIESLQL
     KPGQVVYKCP KCCSIKPDRA HHCSVCKRCI RKMDHHCPWV NNCVGENNQK YFVLFTMYIA
     LISLHALIMV GFHFLHCFEE DWTKCSSFSP PTTVILLILL CFEALLFLIF TSVMFGTQVH
     SICTDETGIE QLKKEERRWA KKTKWMNMKA VFGHPFSLGW ASPFATPDQG KADPYQYVV
//
